Literature DB >> 693070

Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes.

B G Almay, F Johansson, L Von Knorring, L Terenius, A Wahlström.   

Abstract

A series of 37 patients with chronic pain was investigated with regard to neurologic and psychiatric variables. Twenty of the patients were classified as having mainly organic (= somatogenic) pain syndromes while 17 patients were rather suffering from psychogenic pain syndromes. Samples of lumbar cerebrospinal fluid (CSF) were obtained from the patients and analyzed for the presence of opiate receptor-active material, here called endorphins. Patients classified as having mainly organic pain syndromes were found to have significantly lower endorphin levels than patients with predominantly psychogenic pain syndromes. In the total group of patients as well as in the two subgroups, there was a significant correlation between CSF endorphin levels and the depth of depressive symptomatology as reported by the patients. On the other hand, there was no correlation between CSF endorphin levels and extent of anxiety or motor retardation. It is concluded that CSF endorphins reflect central processes involved in chronic pain syndromes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 693070     DOI: 10.1016/0304-3959(78)90037-4

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  18 in total

1.  Acupuncture: a useful treatment modality.

Authors:  L M Rapson
Journal:  Can Fam Physician       Date:  1984-01       Impact factor: 3.275

2.  Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response.

Authors:  J J Lipman; B E Miller; K S Mays; M N Miller; W C North; W L Byrne
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Altered cardiovascular/pain regulatory relationships in chronic pain.

Authors:  S Bruehl; J W Burns; J A McCubbin
Journal:  Int J Behav Med       Date:  1998

4.  Effects of aspirin, naloxone and placebo.

Authors:  A A Mewa; D Rosenbloom; E M Grace; P Brooks; N Bellamy; C Denko; G Norman; W W Buchanan
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

5.  Relationships between CSF levels of endorphins and monoamine metabolites in chronic pain patients.

Authors:  B G Almay; F Johansson; L von Knorring; G Sedvall; L Terenius
Journal:  Psychopharmacology (Berl)       Date:  1980-02       Impact factor: 4.530

6.  Endorphin levels in human cerebrospinal fluid during alcohol intoxication and withdrawal.

Authors:  S Borg; H Kvande; U Rydberg; L Terenius; A Wahlström
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Platelet MAO in patients with idiopathic pain disorders.

Authors:  B G Almay; L von Knorring; L Oreland
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 8.  Recent advances in the treatment of low back pain.

Authors:  A Nachemson
Journal:  Int Orthop       Date:  1985       Impact factor: 3.075

9.  Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with rheumatic diseases.

Authors:  C J Wiedermann; P Sacerdote; E Mur; U Kinigadner; T Wicker; A E Panerai; H Braunsteiner
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

10.  Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin.

Authors:  L von Knorring; B G Almay; J Häggendal; F Johansson; L Oreland; L Wetterberg
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.